Latest in Business and People News
Catch up on all the latest happenings in the industry from the past month.
People News
IMARC Research has announced that Brandy Chittester, currently serving as Chief of Clinical Operations, will assume operational responsibilities as its new President, while founder Sandra Maddock as the company’s CEO focuses on strategic growth. IMARC is also naming James Moat as Director, Project Management Services.
MMS Holdings Inc, announced the addition of Mike Poole, MD to its board of scientific advisors.
Ergomed plc announces the appointment of Richard Barfield as Chief Financial Officer.
Almac Sciences announced the appointment of Sheryl Foster to the position of Vice President of Quality.
Lotus Clinical Research announced the addition of Lee Simon, MD as Principal Advisor, Osteoarthritis Research and Allan Green, MD, PhD as Medical Imaging and Research Advisor.
Clinipace has hired four operational, therapeutic, and medical experts in Leslie Wetherell, Niamh Bresnihan, Gonzalo Rubio, MD, and Heidi Mitchell, MD.
Syneos Health announced the appointment of Patrick Nealon as Executive Vice President and General Manager of Oncology Clinical Development.
The Society for Clinical Research Sites announced that Roger Smith, senior vice president and general manager of Accelerated Enrollment Solutions, has joined the organization’s Leadership Council.
Signant Health has appointed Lawrence Miller as Chief Technology Officer.
Business News
Regeneron has joined TransCelerate as its 20th member.
Quanticate has announced plans to expand its presence in North America with the opening of a new office in Toronto.
Recognition
EY announced Bob Arnesen, Co-Founder and President of eClinical Solutions LLC, is a finalist for the Entrepreneur of The Year 2019 Award in the New England region.
CRF Bracket (known as Signant Health) has been named IT Company of the Year in Romania’s Regional IT & Outsourcing Industry Awards.
How Digital Technology and Remote Assessment Strategies Can Aid Clinical Trial Research
July 24th 2020While there's been hopeful news on treatments and vaccines, sponsors should plan to discuss necessary strategies and contingencies at the outset of new studies or re-opening of halted studies during the COVID-19 pandemic.
